Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

BACKGROUND: Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased incidences of illness and death from coronavirus disease 2019 (Covid-19) have been associated with an older age. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Evan J., Rouphael, Nadine G., Widge, Alicia T., Jackson, Lisa A., Roberts, Paul C., Makhene, Mamodikoe, Chappell, James D., Denison, Mark R., Stevens, Laura J., Pruijssers, Andrea J., McDermott, Adrian B., Flach, Britta, Lin, Bob C., Doria-Rose, Nicole A., O’Dell, Sijy, Schmidt, Stephen D., Corbett, Kizzmekia S., Swanson, Phillip A., Padilla, Marcelino, Neuzil, Kathy M., Bennett, Hamilton, Leav, Brett, Makowski, Mat, Albert, Jim, Cross, Kaitlyn, Edara, Venkata Viswanadh, Floyd, Katharine, Suthar, Mehul S., Martinez, David R., Baric, Ralph, Buchanan, Wendy, Luke, Catherine J., Phadke, Varun K., Rostad, Christina A., Ledgerwood, Julie E., Graham, Barney S., Beigel, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556339/
https://www.ncbi.nlm.nih.gov/pubmed/32991794
http://dx.doi.org/10.1056/NEJMoa2028436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556339/
https://www.ncbi.nlm.nih.gov/pubmed/32991794
http://dx.doi.org/10.1056/NEJMoa2028436

Ejemplares similares